Evidence map›Paper›PMID 26456351›Full record

ArticleNeuropharmacology2016

Convergent phosphomodulation of the major neuronal dendritic potassium channel Kv4.2 by pituitary adenylate cyclase-activating polypeptide.

Raeesa P Gupte, Suraj Kadunganattil, Andrew J Shepherd, Ronald Merrill, William Planer, Michael R Bruchas, Stefan Strack, Durga P Mohapatra

Abstract read
In one paragraph

Article in Neuropharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Angiotensin II Triggers Peripheral Macrophage-to-Sensory Neuron Redox Crosstalk to Elicit Pain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  16. ERK5 Phosphorylates KInternational journal of molecular sciences · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Raeesa P GupteDepartment of Pharmacology, The University of Iowa Roy J. and Lucile A. Carver College of Medicine, Iowa City, IA 52242, USA; Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Washington University Pain Center, Washington University School of Medicine, St. Louis, MO 63110, USA.
Suraj KadunganattilDepartment of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Washington University Pain Center, Washington University School of Medicine, St. Louis, MO 63110, USA.
Andrew J ShepherdDepartment of Pharmacology, The University of Iowa Roy J. and Lucile A. Carver College of Medicine, Iowa City, IA 52242, USA; Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Washington University Pain Center, Washington University School of Medicine, St. Louis, MO 63110, USA.
Ronald MerrillDepartment of Pharmacology, The University of Iowa Roy J. and Lucile A. Carver College of Medicine, Iowa City, IA 52242, USA.
William PlanerDepartment of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Michael R BruchasDepartment of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Stefan StrackDepartment of Pharmacology, The University of Iowa Roy J. and Lucile A. Carver College of Medicine, Iowa City, IA 52242, USA.
Durga P MohapatraDepartment of Pharmacology, The University of Iowa Roy J. and Lucile A. Carver College of Medicine, Iowa City, IA 52242, USA; Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Washington University Pain Center, Washington University School of Medicine, St. Louis, MO 63110, USA; Center for the Investigation of Membrane Excitability Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: mohapatrad@anest.wustl.edu.
University of Iowa · USWashington University in St. Louis · US

Funding

Kinase/Phosphatase-mediated Mitochondrial Restructuring in NeuroprotectionR01NS056244 · NINDS · UNIVERSITY OF IOWA · PI STRACK, STEFAN · 2007 to 2016
$2.9M
Chemokines, TRP Channels and Cancer PainR01NS069898 · NINDS · WASHINGTON UNIVERSITY · PI MOHAPATRA, DURGA PRASANNA · 2011 to 2015
$1.6M
NOCICEPTIN RECEPTORS IN REWARD CIRCUITS AND BEHAVIORR21DA034929 · NIDA · WASHINGTON UNIVERSITY · PI BRUCHAS, MICHAEL R. · 2014 to 2015
$415k
Kinase/phosphatase-mediated Mitochondrial Restructuring in NeuroprotectionR56NS056244 · NINDS · UNIVERSITY OF IOWA · PI STRACK, STEFAN · 2012 to 2012
$378k
NIDA NIH HHS DA034929NIDA NIH HHS R21 DA034929NINDS NIH HHS NS056244NINDS NIH HHS NS069898NINDS NIH HHS R01 NS056244NINDS NIH HHS R01 NS069898NINDS NIH HHS R56 NS056244
6 · The paper itself

Abstract

The endogenous neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) is secreted by both neuronal and non-neuronal cells in the brain and spinal cord, in response to pathological conditions such as stroke, seizures, chronic inflammatory and neuropathic pain. PACAP has been shown to exert various neuromodulatory and neuroprotective effects. However, direct influence of PACAP on the function of intrinsically excitable ion channels that are critical to both hyperexcitation as well as cell death, remain largely unexplored. The major dendritic K(+) channel Kv4.2 is a critical regulator of neuronal excitability, back-propagating action potentials in the dendrites, and modulation of synaptic inputs. We identified, cloned and characterized the downstream signaling originating from the activation of three PACAP receptor (PAC1) isoforms that are expressed in rodent hippocampal neurons that also exhibit abundant expression of Kv4.2 protein. Activation of PAC1 by PACAP leads to phosphorylation of Kv4.2 and downregulation of channel currents, which can be attenuated by inhibition of either PKA or ERK1/2 activity. Mechanistically, this dynamic downregulation of Kv4.2 function is a consequence of reduction in the density of surface channels, without any influence on the voltage-dependence of channel activation. Interestingly, PKA-induced effects on Kv4.2 were mediated by ERK1/2 phosphorylation of the channel at two critical residues, but not by direct channel phosphorylation by PKA, suggesting a convergent phosphomodulatory signaling cascade. Altogether, our findings suggest a novel GPCR-channel signaling crosstalk between PACAP/PAC1 and Kv4.2 channel in a manner that could lead to neuronal hyperexcitability.

Indexed as

AnimalsCells, CulturedCyclic AMPCyclic AMP-Dependent Protein KinasesDendritesEmbryo, MammalianEnzyme InhibitorsFemaleGene Expression RegulationHippocampusHumansMaleMiceMutagenesisMutationNeuronsAdcyap1r1 protein, mouseCyclic AMPCyclic AMP-Dependent Protein KinasesEnzyme InhibitorsNeurotransmitter AgentsPituitary Adenylate Cyclase-Activating PolypeptideReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type IShal Potassium ChannelsExtracellular-signal-regulated kinase (ERK)G protein-coupled receptor (GPCR)Ion channel modulationKv4.2Pituitary adenylate cyclase-activating peptide (PACAP)Potassium channelProtein kinase A (PKA)

Identifiers

PMID26456351
PMCPMC4681664
OpenAlexW1822032151

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.